drugset / Trial / NCT01586117
A Phase II Study of Amifostine for the Prevention of Acute Radiation-Induced Rectal Toxicity
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to evaluate the effect of intrarectal Amifostine administration on acute radiation-induced rectal toxicity in pre-operative chemo-radiotherapy.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | amifostine | Unknown | 1500 mg | Other |